GALT vs JNJ: Which Stock is Better?
Side-by-side comparison of Galectin Therapeutics Inc and Johnson & Johnson in 2026
GALT
Galectin Therapeutics Inc
—
JNJ
Johnson & Johnson
$247.02
Key Metrics Comparison
| Metric | GALT | JNJ | Winner |
|---|---|---|---|
| Market Cap | $142.41M | $375.37B | JNJ |
| P/E Ratio | N/A | 17.35 | JNJ |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze GALT
Full quant analysis
Analyze JNJ
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is GALT or JNJ a better investment?
Comparing GALT and JNJ: Galectin Therapeutics Inc has a market cap of $142.41M while Johnson & Johnson has $375.37B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between GALT and JNJ?
GALT (Galectin Therapeutics Inc) and JNJ (Johnson & Johnson) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: GALT or JNJ?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: GALT or JNJ?
Both GALT and JNJ show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: GALT or JNJ?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: GALT or JNJ?
Johnson & Johnson (JNJ) is larger with a market cap of $375.37B compared to $142.41M for GALT.
Should I buy GALT or JNJ in 2026?
Both GALT and JNJ have investment merit. GALT trades at $N/A while JNJ trades at $247.02. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between GALT and JNJ stock?
Key differences: Market Cap ($142.41M vs $375.37B), P/E Ratio (N/A vs 17.4x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy GALT or JNJ in 2026?
The choice between GALT and JNJ depends on your investment goals. JNJ shows higher revenue growth (0.0%). JNJ has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between GALT and JNJ?
GALT (Galectin Therapeutics Inc) has a market cap of $142.41M, while JNJ (Johnson & Johnson) has a market cap of $375.37B. JNJ is the larger company by market value.